Skip to Content
Merck
CN
  • Contrast enhanced CT attenuation correlates with the GAG content of bovine meniscus.

Contrast enhanced CT attenuation correlates with the GAG content of bovine meniscus.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society (2013-07-09)
Bejamin A Lakin, Daniel J Grasso, Rachel C Stewart, Jonathan D Freedman, Brian D Snyder, Mark W Grinstaff
ABSTRACT

We determined whether contrast-enhanced computed tomography (CECT) attenuation obtained using a µCT scanner correlated with the glycosaminoglycan (GAG) content and distribution in ex vivo bovine menisci. Bovine samples were immersed in different concentrations of the contrast agents CA4+ and Ioxaglate, and the µCT images were compared to Safranin-O staining. CA4+ and Ioxaglate diffusion-in kinetics and the correlation between their CECT attenuations and GAG content were investigated. CA4+ and Ioxaglate both reached steady state in the meniscal regions within 95 h, with tau values of 20.6 ± 3.98 and 25.9 ± 3.71 h (mean ± SD), respectively. Both agents diffused preferentially through the proximal and secondarily through the distal surface. The CA4+ CECT attenuation was strongly and positively correlated with the GAG content of the meniscus regions (R(2)  = 0.89, p < 0.001) at low concentrations (12 mgI/ml), while the Ioxaglate CECT attenuation was moderately and negatively correlated with the GAG content (R(2)  = 0.51, p = 0.03) at 60 mgI/ml. CECT can image ex vivo menisci, and the CA4+, compared to Ioxaglate, enhanced attenuation strongly correlates with the GAG content and distribution in bovine meniscus.

MATERIALS
Product Number
Brand
Product Description

Ioxaglic acid, European Pharmacopoeia (EP) Reference Standard
USP
Ioxaglic acid, United States Pharmacopeia (USP) Reference Standard